No definition available.
Sequelae of infectious and parasitic diseases
EFO MESH Endpoint Browser PheWeb
AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1151 |
4. Check minimum number of eventsNone |
1151 |
5. Include endpoints |
3303 |
6. Filter based on genotype QC (FinnGen only) |
3212 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Sequelae of infectious and parasitic diseases
based on the number of shared cases.
Similar with more cases:
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 38037 | 16544 | 20739 |
| Only index persons | 26574 | 12375 | 14199 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.54 | 0.47 | 0.58 |
| Only index persons | 0.50 | 0.45 | 0.54 |
| Median age at first event (years) | |||
| Whole population | 38.55 | 41.13 | 35.62 |
| Only index persons | 23.03 | 26.29 | 20.18 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3212 | 1555 | 1657 |
| Unadjusted period prevalence (%) | 0.66 | 0.55 | 0.76 |
| Median age at first event (years) | 23.74 | 19.80 | 27.45 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3302
- Matched controls
- 33020
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
6059.4
307.7
524
*
07997
ICD-8 Finland
Other viral diseases, Viroses suspectae
+∞
307.7
784
*
07999
ICD-8 Finland
Other viral diseases, Viral infection, unspecified
+∞
307.7
780
*
B91
ICD-10 Finland
Sequelae of poliomyelitis
903.5
258.9
251
*
07988
ICD-8 Finland
Other viral diseases
+∞
242.8
230
*
07900
ICD-8 Finland
Other viral diseases, Molluscum contagiosum
+∞
151.2
144
*
07910
ICD-8 Finland
Other viral diseases, Viral warts
+∞
117.4
112
*
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
9.0
98.7
123
141
Y3409
ICD-8 Finland
Follow-up examination of illness, accident or surgery, Treated inactive pulmonary tuberculosis
36.2
91.1
57
16
1380A
ICD-9 Finland
Late effects of acute poliomyelitis[SEQUELAE POLIOMYELITIDIS]
+∞
76.3
73
*
1370A
ICD-9 Finland
Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,TUBERKULOOSIARPI]
+∞
74.2
71
*
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
4.6
74.0
180
406
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
56.9
734
4067
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
19.4
56.3
44
23
04499
ICD-8 Finland
Late effects of actue poliomyelitis
+∞
55.4
53
*
N70
ICPC
Poliomyelitis
189.8
54.1
56
*
1370X
ICD-9 Finland
Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,MUU JÄLKITILA]
+∞
53.3
51
*
01908
ICD-8 Finland
Late effects of tuberculosis, Sequelae aliae o tuberculosis organorum respirationis
+∞
51.2
49
*
B90.0
ICD-10 Finland
Sequelae of central nervous system tuberculosis
+∞
50.1
48
*
07981
ICD-8 Finland
Other viral diseases, Infectio virosa adeno alia
+∞
49.1
47
*
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
453.9
45.4
45
*
J96.1
ICD-10 Finland
Chronic respiratory failure
4.2
44.9
120
291
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
3.4
43.6
164
504
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.5
41.3
289
1240
01102
ICD-8 Finland
Pulmonary tuberculosis, Non cavernosa
12.7
40.1
39
31
R03AC02
ATC
salbutamol; inhalant
1.6
38.9
1723
13314
R03BB01
ATC
ipratropium bromide; inhalant
2.8
38.4
200
741
R03AC12
ATC
salmeterol; inhalant
2.8
38.2
201
749
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
37.9
389
1959
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
37.4
500
2769
B90.2
ICD-10 Finland
Sequelae of tuberculosis of bones and joints
+∞
35.5
34
*
49300
ICD-8 Finland
Asthma, bronchiale
3.5
35.1
124
366
R03DA04
ATC
theophylline; systemic, rectal
2.4
34.1
241
1037
J47
ICD-10 Finland
Bronchiectasis
4.4
34.0
87
204
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
3.6
29.6
98
277
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
29.3
588
3667
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
2.4
28.1
211
932
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.3
28.1
226
1029
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
27.0
335
1799
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
4.1
26.5
72
177
R03BB04
ATC
tiotropium bromide; inhalant
1.9
25.9
342
1873
78880
ICD-8 Finland
Other general symptoms, Pyrexia of unknown origin
6.7
25.9
41
62
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
25.8
323
1739
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.0
25.7
114
387
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
25.6
834
5854
R03BA01
ATC
beclometasone; inhalant
1.8
24.8
449
2712
H02AB06
ATC
prednisolone; systemic
1.5
24.6
1437
11369
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
26.9
23.5
32
12
48609
ICD-8 Finland
Pneumonia, unspecified
3.5
22.5
77
223
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
22.5
222
1096
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
4.2
21.7
57
137
J01AA02
ATC
doxycycline; systemic
1.5
20.5
2406
21340
J01FA06
ATC
roxithromycin; oral
1.4
20.0
1201
9446
H02AB04
ATC
methylprednisolone; systemic
1.7
19.6
435
2765
48509
ICD-8 Finland
Bronchopneumonia, unspecified
3.5
18.5
63
182
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
18.4
563
3864
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
3.0
18.1
79
266
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
3.6
17.7
59
168
49099
ICD-8 Finland
Bronchitis, unspecified
3.7
17.6
55
150
R03BA05
ATC
fluticasone; inhalant
1.5
17.0
518
3546
01904
ICD-8 Finland
Late effects of tuberculosis, Adhaesiones pleurae
+∞
16.7
16
*
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.7
16.4
309
1878
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
5.0
16.2
34
68
R04.2
ICD-10 Finland
Haemoptysis
2.3
15.5
112
487
J45.8
ICD-10 Finland
Mixed asthma
2.5
15.2
99
411
R03BA02
ATC
budesonide; inhalant
1.5
15.1
503
3502
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
3.5
14.8
50
144
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.3
14.8
110
485
01909
ICD-8 Finland
Late effects of tuberculosis, Sequelae NUD o tuberculosis organorum respirationis
+∞
14.6
14
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.0
14.6
155
787
59010
ICD-8 Finland
Infections of kidney, Pyelonephritis
3.1
14.4
60
197
R06.0
ICD-10 Finland
Dyspnoea
1.4
14.2
737
5582
79199
ICD-8 Finland
Headache
3.3
14.2
53
163
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.4
13.7
93
394
J01DA01
ATC
[U] cefalexin
1.3
13.6
1858
16277
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.0
13.6
153
793
B90.1
ICD-10 Finland
Sequelae of genitourinary tuberculosis
+∞
13.5
13
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.0
13.4
154
805
78310
ICD-8 Finland
Symptoms referable to respiratory system, Haemoptysis
6.3
13.3
22
35
R03BB02
ATC
oxitropium bromide; inhalant
3.8
13.1
39
103
J01MA12
ATC
levofloxacin; systemic
1.5
13.0
523
3775
N02AX02
ATC
tramadol; systemic, rectal
1.3
13.0
1227
10183
M05BA04
ATC
alendronic acid; oral
1.7
12.8
230
1379
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
12.7
576
4253
0110A
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung, infiltrative[TUBERCULOSIS PULMONUM INFILTRATIVA, BAKTER.VARMA]
32.1
12.6
16
5
C03CA01
ATC
furosemide; systemic
1.4
12.5
886
7037
B90.8
ICD-10 Finland
Sequelae of tuberculosis of other organs
+∞
12.5
12
*
07980
ICD-8 Finland
Other viral diseases, Infectio virosa ECHO
+∞
12.5
12
*
TGC00
NOMESCO Finland
Bronchial lavation
2.5
12.4
76
307
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
12.4
991
8013
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
4.2
12.4
32
76
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
11.6
12.3
22
19
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
12.3
236
1441
N03AX16
ATC
[U] pregabalin
1.4
12.2
628
4735
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
6.0
12.1
21
35
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
2.3
11.9
89
395
J01MA14
ATC
moxifloxacin; systemic
1.6
11.7
253
1594
A10AA01, ,
ATC
2.3
11.7
90
404
R96
ICPC
Asthma
1.7
11.5
236
1465
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.9
11.5
149
810
01930
ICD-8 Finland
Late effects of tuberculosis, Columnae vertebralis
+∞
11.5
11
*
07940
ICD-8 Finland
Other viral diseases, Foot and mouth disease
+∞
11.5
11
*
M89.6
ICD-10 Finland
Osteopathy after poliomyelitis
+∞
11.5
11
*
01901
ICD-8 Finland
Late effects of tuberculosis, Emphysema
+∞
11.5
11
*
A86
ICD-10 Finland
Unspecified viral encephalitis
5.1
11.3
23
45
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.4
11.3
75
316
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
3.8
11.2
33
87
7863A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Haemoptysis
5.6
11.2
21
38
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.3
11.1
82
361
R03DC03
ATC
montelukast; oral
1.4
10.8
430
3092
79388
ICD-8 Finland
Observation, without need for further medical care, Morbi alii definiti
4.2
10.8
28
67
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
10.8
844
6782
H3603, E103,
ICD-10 Finland
3.5
10.7
36
104
J01FF01
ATC
clindamycin; systemic
1.3
10.5
729
5753
R03AC03
ATC
terbutaline; inhalant
1.5
10.5
371
2609
B94.80
ICD-10 Finland
Late effects of bacterial meningitis
110.4
10.4
11
*
1370D
ICD-9 Finland
Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,PLEURAFIBROOSI]
+∞
10.4
10
*
1373X
ICD-9 Finland
Late effects of tuberculosis of bones and joints
+∞
10.4
10
*
H3600, E103,
ICD-10 Finland
3.1
10.3
41
132
127
Kela drug reimbursment
Transplant complication
2.9
10.3
47
164
L28
ICPC
Limited function/disability (L)
1.4
10.2
460
3384
A10AB01
ATC
insulin (human); parenteral
2.0
10.1
110
565
03400
ICD-8 Finland
Streptococcal sore throat and scarlet fever, Streptococcal sore throat
4.2
10.1
26
62
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
10.0
1206
10245
R03AC13
ATC
formoterol; inhalant
1.8
9.9
141
792
H02AB07
ATC
prednisone; oral
1.4
9.8
386
2770
204
Kela drug reimbursment
Leukemia lymphatica
2.1
9.7
93
457
78080
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Meningismus
55.2
9.6
11
*
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
4.3
9.6
24
56
J01DA06
ATC
[U] cefuroxime
1.4
9.5
377
2706
34599
ICD-8 Finland
Epilepsy, Other and unspecified
4.8
9.5
21
44
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
15.1
9.5
15
10
R02
ICPC
Shortness of breath/dyspnoea
1.5
9.4
314
2179
A15.3
ICD-10 Finland
Tuberculosis of lung, confirmed by unspecified means
100.3
9.4
10
*
01210
ICD-8 Finland
Other respiratory tuberculosis, Tuberculosis pleurae, pleuritis exsudativa tuberculosa
30.1
9.4
12
*
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.7
9.4
154
902
01903
ICD-8 Finland
Late effects of tuberculosis, Fibrosis pulmonum
+∞
9.4
9
*
B94.8
ICD-10 Finland
Sequelae of other specified infectious and parasitic diseases
+∞
9.4
9
*
07959
ICD-8 Finland
Other viral diseases, Virosis cytomegalica NUD
+∞
9.4
9
*
J01DA09
ATC
[U] cefadroxil
1.3
9.2
716
5727
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
4.2
9.2
24
58
42700
ICD-8 Finland
Symptomatic heart disease, Congestive heart failure
4.3
9.1
23
54
A16.2
ICD-10 Finland
Tuberculosis of lung, without mention of bacteriological or histological confirmation
36.8
9.0
11
*
R50.9
ICD-10 Finland
Fever, unspecified
1.4
9.0
389
2839
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
8.9
209
1343
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
8.8
1404
12271
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
8.8
679
5424
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
8.8
414
3064
SPAT1229
SPAT
Assessment of need for aid
1.6
8.7
195
1239
J45
ICD-10 Finland
Asthma
1.5
8.7
255
1724
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
8.7
486
3701
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
8.7
451
3394
0310A
ICD-9 Finland
Diseases due to other mycobacteria, Pulmonary
50.1
8.7
10
*
01106
ICD-8 Finland
Pulmonary tuberculosis, Pulmonum alia sive NUD
50.1
8.7
10
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
8.6
366
2663
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.4
8.6
332
2374
34609
ICD-8 Finland
Migraine, Unspecified
3.7
8.4
26
71
5901A
ICD-9 Finland
Infections of kidney, Acute pyelonephritis
3.1
8.4
34
111
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
7.9
8.4
18
23
01510
ICD-8 Finland
Tuberculosis of bones and joints, Of hip
+∞
8.3
8
*
01900
ICD-8 Finland
Late effects of tuberculosis, Bronchiectasia
+∞
8.3
8
*
01931
ICD-8 Finland
Late effects of tuberculosis, Coxae
+∞
8.3
8
*
1398X
ICD-9 Finland
Late effects of other infectious and parasitic diseases, Late effects of other and unspecified infectious and parasitic diseases
+∞
8.3
8
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.2
8.3
63
283
L04AX01
ATC
azathioprine; systemic
1.8
8.3
110
606
N03AG01
ATC
valproic acid; systemic, rectal
1.7
8.2
161
990
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
8.2
750
6122
N03AX12
ATC
[U] gabapentin; oral
1.4
8.1
421
3165
A02BA02
ATC
ranitidine; systemic
1.3
8.1
519
4033
Z94.0
ICD-10 Finland
Kidney transplant status
3.0
8.0
34
114
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.0
8.0
85
434
78410
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Emesis
6.3
8.0
20
32
N06AB04
ATC
citalopram; systemic
1.3
8.0
567
4471
01107
ICD-8 Finland
Pulmonary tuberculosis, Suspecta
7.2
7.9
18
25
N05CF01
ATC
zopiclone; oral
1.3
7.9
902
7562
N05BA04
ATC
oxazepam; oral
1.3
7.9
694
5635
N05BA01
ATC
diazepam; systemic, rectal
1.4
7.8
345
2528
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.3
7.7
57
253
J01FA10
ATC
azithromycin; systemic
1.2
7.7
1512
13455
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
7.7
570
4524
XG410
NOMESCO Finland
Flow-volume spirometry
1.9
7.6
98
534
59000
ICD-8 Finland
Infections of kidney, Pyelonephritis chronica
4.5
7.6
18
40
1240
FHL
Bronchoscopy
2.6
7.6
42
163
85000
ICD-8 Finland
Concussion, Current or unspecified
2.1
7.6
68
327
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
2.9
7.4
33
114
N03AX18
ATC
lacosamide; systemic
3.4
7.4
25
73
Y0209
ICD-8 Finland
Examination of the nervous system and sensory organs, Nervous system
3.3
7.4
27
83
R95
ICPC
Chron obstructive pulmonary disease
2.0
7.3
73
365
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
2.3
7.3
54
240
B94.89
ICD-10 Finland
Sequelae of other specified infectious and parasitic diseases
+∞
7.3
7
*
1370C
ICD-9 Finland
Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,BRONKIEKTASIAT]
+∞
7.3
7
*
06608
ICD-8 Finland
Late effects of viral encephalitis, Alii casus postencephalitici
+∞
7.3
7
*
L01BB01, ,
ATC
10.9
7.3
13
12
A10AA02, ,
ATC
1.8
7.3
108
616
01101
ICD-8 Finland
Pulmonary tuberculosis, Cavernosa
9.4
7.3
14
15
S72.4
ICD-10 Finland
Fracture of lower end of femur
3.2
7.3
28
89
68409
ICD-8 Finland
Impetigo, Unspecified
15.8
7.2
11
7
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
7.2
335
2473
J01MA02
ATC
ciprofloxacin; systemic
1.2
7.2
1058
9111
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.9
7.2
90
487
L04AA01
ATC
[U] ciclosporin
2.7
7.1
37
139
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.7
7.1
116
680
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.8
7.1
107
614
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
7.0
237
1652
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
7.0
480
3765
Y0899
ICD-8 Finland
Investigation of musculoskeletal system
3.9
7.0
20
52
N05CD07
ATC
temazepam; oral
1.4
7.0
330
2444
J01DA08
ATC
[U] cefaclor
1.5
7.0
210
1430
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.6
6.9
138
855
J02AC01
ATC
fluconazole; systemic
1.2
6.9
975
8354
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
4.0
6.9
19
48
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.0
6.9
74
381
N05CD02
ATC
nitrazepam; oral
2.2
6.9
52
234
L04AA06
ATC
mycophenolic acid; systemic
2.3
6.8
48
209
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
6.8
420
3241
R05FB02
ATC
cough suppressants and expectorants; systemic
1.2
6.8
993
8534
R53
ICD-10 Finland
Malaise and fatigue
1.3
6.8
634
5177
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
10.9
6.8
12
11
A02BC05
ATC
esomeprazole; systemic
1.2
6.8
1064
9213
N06AX11
ATC
mirtazapine; oral
1.2
6.8
894
7599
B00.4
ICD-10 Finland
Herpesviral encephalitis
40.1
6.8
8
*
A15.2
ICD-10 Finland
Tuberculosis of lung, confirmed histologically
16.7
6.7
10
6
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
6.7
535
4279
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.2
6.7
51
230
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.0
6.7
65
323
R05CB01
ATC
acetylcysteine; inhalant, oral
2.3
6.7
47
205
A01AB10
ATC
natamycin; local oral
1.9
6.6
76
400
R03AK08
ATC
formoterol and beclometasone; inhalant
1.7
6.6
103
598
T89
ICPC
Diabetes insulin dependent
1.8
6.5
100
577
P01AB01
ATC
metronidazole; oral, rectal
1.2
6.5
1020
8824
N06AX16
ATC
venlafaxine; oral
1.4
6.5
345
2606
R5140
NOMESCO Finland
Monitoring the use of the aid
1.4
6.4
272
1976
A15.9
ICD-10 Finland
Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically
70.0
6.4
7
*
01500
ICD-8 Finland
Tuberculosis of bones and joints, Of vertebral column
70.0
6.4
7
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
2.9
6.4
28
96
01220
ICD-8 Finland
Other respiratory tuberculosis, Pleurisy with effusion without mention of cause
7.4
6.4
14
19
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
6.4
768
6455
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.7
6.4
111
664
N02AC04
ATC
dextropropoxyphene; oral
1.7
6.3
104
612
J01DB01
ATC
cefalexin; oral
1.2
6.3
2389
22475
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
6.3
992
8580
A02BC02
ATC
pantoprazole; systemic
1.2
6.3
1888
17365
47099
ICD-8 Finland
Influenza, unqualified
3.5
6.3
21
61
A02BC03
ATC
lansoprazole; oral
1.2
6.3
750
6299
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.8
6.3
94
539
N05AH04
ATC
quetiapine; oral
1.3
6.3
454
3585
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
18.0
6.3
9
5
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
6.3
267
1943
07951
ICD-8 Finland
Other viral diseases, Virosis cytomegalica asquisita
+∞
6.3
6
*
07998, ,
ICD-8 Finland
+∞
6.3
6
*
1374X
ICD-9 Finland
Late effects of tuberculosis of other specified organs
+∞
6.3
6
*
E0000UV, ,
ATC
1.2
6.2
1050
9141
Y3429
ICD-8 Finland
Follow-up examination of illness, accident or surgery, Other inactive tuberculosis cases
26.7
6.2
8
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
3.0
6.2
26
87
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
6.2
238
1700
71490
ICD-8 Finland
Other specified forms of arthritis, Arthritis postinfectiosa NUD
6.3
6.2
15
24
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
6.1
473
3765
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.5
6.1
214
1501
SPAT1262
SPAT
Handing over of treatment supplies
1.3
6.1
413
3228
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
5.7
6.1
16
28
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
6.1
700
5850
AA1AD
NOMESCO Finland
CT of head and brain
1.3
6.1
672
5591
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
3.8
6.1
18
48
C03DA01
ATC
spironolactone; oral
1.4
6.1
294
2186
J01CA04
ATC
amoxicillin; systemic
1.2
6.1
2309
21680
Y0599
ICD-8 Finland
Investigation of digestive system
2.2
6.0
46
208
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
172
756
2.35
23.17
3.9
2.8
—
—
—
0
0
551
3864
1.51
16.09
2.9
2.4
13.05
13.20
umol/l
0.16
512
3585
481
3296
1.54
15.62
3.1
2.5
22.79
23.06
%
0.15
416
2813
1400
11658
1.35
15.19
7.6
6.3
8.58
8.60
%
0.09
1326
10901
1391
11600
1.34
14.83
7.1
6.0
2.89
2.84
%
0.35
1317
10835
1430
11979
1.34
14.77
7.2
6.0
27.30
27.61
%
0.51
1356
11240
504
3538
1.50
14.54
3.0
2.4
2.32
2.33
g/l
0.18
466
3262
68
240
2.87
14.42
5.7
3.8
—
—
—
0
0
1347
11229
1.34
14.20
7.0
6.0
0.66
0.67
%
0.18
1273
10464
1515
12851
1.33
14.15
7.2
6.0
0.19
0.19
e9/l
0.19
1350
11317
1399
11805
1.32
13.26
6.9
5.8
57.63
57.56
%
0.09
1325
11069
1458
12394
1.32
13.03
6.9
5.8
0.59
0.58
e9/l
0.55
1297
10749
1460
12419
1.31
12.96
6.9
5.8
0.04
0.04
e9/l
0.23
1300
10764
535
3984
1.41
11.10
2.0
1.8
—
—
—
0
0
1476
12755
1.28
10.97
7.0
5.9
1.85
1.92
e9/l
1.26
1332
11340
1388
11961
1.28
10.34
8.2
6.4
1.21
1.21
mmol/l
0.02
1167
10144
1264
10787
1.28
10.13
7.3
5.8
1.21
1.21
mmol/l
0.23
1154
9840
1178
9979
1.28
9.97
2.5
2.2
78.36
76.46
nmol/l
1.42
1065
8994
386
2777
1.44
9.64
7.2
7.2
11.73
12.26
kpa
1.09
370
2642
386
2777
1.44
9.64
7.2
7.2
5.25
5.08
kpa
2.67
368
2641
95
477
2.02
9.33
1.9
1.5
—
—
—
0
0
1313
11346
1.26
9.23
14.6
15.3
1.25
1.28
inr
0.46
422
3289
1607
14254
1.25
8.86
9.8
8.9
4.24
4.14
e9/l
0.85
1419
12484
379
2771
1.42
8.64
7.3
7.2
1.81
1.03
mmol/l
3.39
313
2160
2004
18252
1.25
8.58
4.8
3.9
13.02
11.82
mm/h
2.80
1886
16974
226
1502
1.54
8.35
3.5
3.4
5.37
5.17
kpa
2.45
217
1419
94
491
1.94
8.30
3.2
3.7
58.96
58.43
%
0.18
94
491
318
2281
1.44
8.05
2.1
2.1
0.21
0.22
g/l
0.14
297
2126
91
476
1.94
8.01
3.0
3.4
4.36
4.24
e9/l
0.23
91
476
214
1428
1.53
7.78
3.6
3.4
1.88
1.68
mmol/l
0.30
161
1059
103
567
1.84
7.77
5.1
4.4
2.63
2.58
mmol/l
0.07
70
370
35
122
2.89
7.74
1.2
1.1
—
—
—
0
0
501
3904
1.33
7.65
3.8
3.3
0.81
0.82
mmol/l
1.31
465
3671
368
2734
1.39
7.63
2.0
1.7
—
—
—
0
0
1215
10575
1.24
7.57
5.3
4.7
35.16
35.61
g/l
2.04
1111
9862
63
295
2.16
7.51
1.1
1.1
—
—
—
0
0
336
2465
1.40
7.50
7.7
7.6
94.95
95.56
%
0.75
329
2374
370
2761
1.38
7.47
2.0
1.7
—
—
—
0
0
89
477
1.89
7.32
6.4
6.2
213.38
573.75
iu/ml
1.16
16
69
1100
9504
1.24
7.27
4.1
3.6
51.99
54.98
ng/l
0.11
747
6307
32
111
2.90
7.16
2.0
1.8
—
—
—
0
0
1589
14350
1.21
6.54
5.8
4.6
6.87
6.74
mmol/l
1.17
1504
13470
1425
12738
1.21
6.53
6.2
5.9
10.94
11.63
umol/l
1.34
1345
12083
30
106
2.85
6.52
5.8
3.5
—
—
—
0
0
49
227
2.18
6.06
2.1
1.7
—
—
—
0
0
655
5446
1.25
5.96
1.8
1.6
19.32
20.25
nmol/l
0.88
587
4695
2049
19036
1.20
5.95
8.4
7.2
78.19
77.60
u/l
0.24
1942
17963
287
2135
1.38
5.91
9.6
7.2
10.13
9.84
mmol/l
0.29
262
2032
628
5204
1.26
5.88
3.2
2.6
5.37
5.57
e6/l
0.15
579
4668
310
2337
1.36
5.88
2.1
2.1
359.45
371.30
nmol/l
0.49
289
2133
242
1751
1.41
5.87
1.8
1.7
—
—
—
0
0
400
3137
1.31
5.80
7.6
5.6
1.06
1.03
mmol/l
1.41
365
2910
749
6349
1.23
5.69
4.4
3.9
0.00
0.00
estimate
1.28
284
2128
94
556
1.71
5.66
1.4
1.3
—
—
—
0
0
94
556
1.71
5.66
1.4
1.3
—
—
—
0
0
798
6825
1.22
5.55
3.3
3.0
1422.11
1579.01
ng/l
0.47
678
5764
853
7347
1.22
5.53
2.4
2.2
264.14
236.07
u/l
0.22
798
6906
891
7709
1.21
5.51
3.1
2.5
60.64
69.14
u/l
0.36
828
7140
87
508
1.73
5.50
3.2
2.5
16.26
16.27
%
0.01
48
252
180
1251
1.46
5.45
9.4
9.6
25.08
24.31
mmol/l
2.55
167
1207
1218
10865
1.19
5.40
11.5
9.3
0.00
0.00
e9/l
0.27
1008
8873
282
2128
1.36
5.33
8.2
6.9
1.37
1.39
mmol/l
0.09
270
2074
249
1851
1.37
5.18
2.8
2.7
10.70
10.54
g/l
0.23
228
1695
235
1731
1.38
5.17
4.3
3.8
107.19
90.92
ng/l
0.95
187
1508
16
36
4.46
5.04
9.6
6.2
—
—
—
0
0
1725
15910
1.18
5.03
5.0
4.4
30.26
1463.34
e6/l
2.86
23
238
452
3671
1.27
4.99
2.3
2.1
30.23
29.84
s
0.37
442
3550
213
1559
1.39
4.88
1.4
1.3
485.11
219.84
u/ml
0.94
203
1441
137
927
1.50
4.78
4.0
3.7
24.56
24.81
mmol/l
0.48
128
849
12
21
5.73
4.75
1.3
1.1
—
—
—
0
0
14
30
4.68
4.67
1.3
1.1
—
—
—
0
0
195
1419
1.40
4.63
1.7
1.6
—
—
—
0
0
208
1531
1.38
4.62
6.7
6.8
25.37
24.40
mmol/l
3.08
202
1455
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
31
134
2.33
4.59
1.2
1.1
—
—
—
0
0
724
6243
1.20
4.53
2.6
2.2
2.94
2.98
mg/l
0.14
633
5286
657
5613
1.21
4.53
1.9
1.7
1.03
1.09
mg/l
0.16
505
4242
920
8107
1.19
4.53
3.4
3.3
2.34
2.35
mmol/l
1.12
808
7168
24
93
2.59
4.47
1.3
1.2
—
—
—
0
0
1097
9821
1.18
4.46
2.1
2.0
98.80
95.48
pmol/l
0.94
609
5230
1193
10761
1.17
4.40
3.3
2.8
127.88
128.40
ug/l
0.03
1124
9983
69
405
1.72
4.36
1.3
1.5
—
—
—
0
0
322
2551
1.29
4.34
3.9
3.4
—
—
—
0
0
335
2672
1.28
4.29
2.9
2.5
1.77
1.78
%
0.05
300
2346
175
1269
1.40
4.27
10.0
10.1
—
—
—
0
0
13
29
4.50
4.24
1.4
1.2
—
—
—
0
0
116
779
1.51
4.23
1.5
1.6
92.51
8.31
iu/ml
0.55
28
149
249
1924
1.32
4.06
2.8
2.5
71.96
70.43
e9/l
0.25
192
1474
107
715
1.51
4.02
1.7
1.7
—
—
—
0
0
49
268
1.84
3.95
1.4
1.5
—
—
—
0
0
49
268
1.84
3.95
1.4
1.5
—
—
—
0
0
924
8246
1.17
3.80
3.3
3.2
30.50
35.44
u/l
1.60
863
7825
14
44
3.19
3.77
1.2
1.1
—
—
—
0
0
278
2214
1.28
3.63
5.3
3.5
2.00
2.00
mmol/l
0.00
242
1830
764
6743
1.17
3.59
4.1
3.1
0.35
0.45
e6/l
0.83
615
5146
278
2221
1.27
3.54
5.1
3.5
5.92
5.85
kpa
0.56
270
2152
25
111
2.26
3.54
1.2
1.2
—
—
—
0
0
103
703
1.48
3.53
1.5
1.6
0.22
0.24
g/l
0.79
97
665
198
1517
1.32
3.46
1.3
1.3
30.23
53.59
au/ml
—
9
95
712
6271
1.17
3.42
4.7
3.9
90.46
89.89
%
0.25
692
6107
1291
11876
1.14
3.41
5.4
4.9
0.00
0.00
estimate
0.50
291
2209
56
334
1.69
3.41
1.4
1.5
—
—
—
0
0
25
113
2.22
3.41
22.2
23.9
94.42
110.92
ug/l
0.98
19
93
106
735
1.46
3.37
1.5
1.6
1.13
1.18
g/l
1.09
100
696
144
1055
1.38
3.37
1.5
2.0
42.79
39.31
u/l
1.25
129
948
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
114
807
1.43
3.26
4.1
2.7
0.36
0.35
u/ml
0.09
72
454
1300
11992
1.14
3.26
4.0
3.6
0.01
0.00
estimate
0.27
288
2132
188
1445
1.32
3.23
1.5
1.5
—
—
—
0
0
286
2323
1.25
3.20
3.3
2.5
33.94
61.25
u/l
0.74
247
2025
1291
11916
1.14
3.19
4.1
3.6
0.00
0.00
estimate
0.08
309
2362
550
4777
1.18
3.12
4.3
3.7
243.94
405.09
ng/l
1.27
438
3650
1745
16435
1.13
3.09
3.2
3.0
—
—
—
0
0
827
7419
1.15
3.09
4.1
3.2
42.86
84.14
e6/l
1.63
666
5720
62
391
1.60
3.08
1.5
1.7
—
—
—
0
0
62
391
1.60
3.08
1.5
1.7
—
—
—
0
0
94
651
1.46
3.04
1.4
1.4
—
—
—
0
0
821
7369
1.15
3.04
3.9
3.2
7.47
7.81
mmol/l
1.34
705
6239
16
62
2.59
3.04
1.3
1.1
—
—
—
0
0
17
68
2.51
3.04
1.3
1.1
—
—
—
0
0
599
5252
1.17
3.02
1.3
1.3
2.03
1.59
u/ml
0.30
153
1435
598
5246
1.17
3.00
1.8
1.7
16935927.12
35894948.40
pmol/l
0.49
496
4399
128
940
1.38
2.99
1.3
1.3
0.78
0.90
u/ml
0.10
11
90
42
242
1.75
2.94
1.1
1.0
—
—
—
0
0
526
4575
1.18
2.93
1.9
1.8
1182.13
1180.50
nmol/l
0.01
406
3461
101
715
1.43
2.92
1.2
1.3
—
—
—
0
0
8
17
4.71
2.92
1.3
1.1
—
—
—
0
0
764
6845
1.15
2.89
3.7
3.2
510.50
350.94
mg/l
0.38
512
4434
799
7189
1.15
2.84
4.5
3.8
10.41
8.03
mg/mmol
0.74
532
4611
19
83
2.30
2.84
1.1
1.1
—
—
—
0
0
28
144
1.95
2.79
2.7
2.8
42150.00
42006.58
ug/l
0.02
28
144
15
59
2.55
2.78
1.1
1.2
—
—
—
0
0
241
1954
1.25
2.77
4.5
3.8
1.22
1.22
mmol/l
0.21
211
1699
20
91
2.21
2.73
1.2
1.1
88.71
273.60
ng/l
—
7
20
11
34
3.24
2.72
1.2
1.2
—
—
—
0
0
91
643
1.43
2.69
1.1
1.1
—
—
—
0
0
95
677
1.42
2.68
1.3
1.3
—
—
—
0
0
123
916
1.36
2.67
1.7
1.8
—
—
—
0
0
49
304
1.62
2.64
1.1
1.1
—
—
—
0
0
207
1660
1.26
2.63
2.5
2.4
17.31
23.22
au/ml
0.43
17
149
182
1439
1.28
2.59
1.8
1.8
1.55
1.42
g/l
0.19
162
1327
82
573
1.44
2.58
2.2
2.3
48.34
117.61
ug/min
2.08
50
357
130
982
1.34
2.58
2.1
2.0
1.68
1.68
ug/l
0.00
114
856
134
1017
1.33
2.58
1.9
2.0
—
—
—
0
0
50
314
1.60
2.58
1.3
1.4
—
—
—
0
0
43
260
1.66
2.57
1.4
1.8
—
—
—
0
0
16
68
2.36
2.55
1.3
1.1
—
—
—
0
0
45
277
1.63
2.52
6.5
6.5
6.46
7.64
mmol/l
1.83
40
234
112
831
1.36
2.51
1.6
1.6
136.00
288.65
titre
—
5
37
526
4633
1.16
2.50
1.5
1.4
2.58
2.46
g/l
0.58
324
2935
1012
9315
1.12
2.49
4.4
3.7
—
—
—
0
0
103
757
1.37
2.45
1.7
1.8
—
—
—
0
0
19
89
2.14
2.44
2.8
3.0
8.20
7.85
mg/l
0.10
12
74
343
2923
1.19
2.44
2.4
2.4
127.85
133.79
ug/g
0.13
266
2365
79
558
1.43
2.38
1.6
1.7
—
—
—
0
0
236
1945
1.23
2.37
3.0
2.5
66.66
66.64
g/l
0.01
212
1777
55
362
1.53
2.35
1.4
1.4
—
—
—
0
0
81
577
1.41
2.33
1.6
1.7
—
—
—
0
0
17
78
2.19
2.31
1.2
1.7
—
—
—
0
0
71
495
1.44
2.30
1.3
1.2
2.86
4.07
u/ml
—
9
38
74
520
1.43
2.30
2.6
2.1
130.73
129.80
g/l
0.11
62
370
14
59
2.38
2.29
1.4
1.1
—
—
—
0
0
313
2664
1.19
2.27
3.9
4.1
241.27
245.25
u/l
0.22
295
2509
281
2369
1.20
2.26
3.9
4.0
30.41
19.31
ug/l
0.32
236
1927
27
149
1.82
2.24
1.3
1.1
1.05
1.05
ratio
0.07
13
58
14
60
2.34
2.21
1.1
1.1
—
—
—
0
0
14
60
2.34
2.21
1.2
1.1
—
—
—
0
0
5
9
5.56
2.21
1.2
1.0
—
—
—
0
0
135
1052
1.30
2.20
1.9
1.8
1.39
1.54
g/l
0.93
116
901
88
645
1.37
2.17
4.1
2.9
1.72
1.52
mg/l
1.14
82
597
220
1819
1.22
2.17
4.5
2.9
4.90
4.61
kpa
1.09
208
1755
6
14
4.29
2.15
1.0
1.4
—
—
—
0
0
256
2153
1.20
2.13
2.4
2.4
7.84
7.30
ug/l
0.13
220
1861
27
152
1.78
2.11
1.2
1.2
—
—
—
0
0
62
429
1.45
2.11
1.8
1.5
107.38
120.91
u/ml
0.43
16
86
2309
23817
0.90
2.11
3.9
3.8
1.34
1.33
mmol/l
0.18
2131
21956
94
702
1.35
2.07
3.2
2.4
3.54
3.60
g/l
0.15
88
663
9
31
2.91
2.07
1.4
2.5
—
—
—
0
0
10
37
2.71
2.07
1.0
1.4
—
—
—
0
0
17
83
2.05
2.01
1.4
1.1
—
—
—
0
0
143
1142
1.26
1.95
4.2
2.6
1.34
1.24
%
0.43
143
1134
93
701
1.34
1.95
3.3
3.1
47.62
57.57
mg/l
0.45
72
568
8
27
2.97
1.93
1.9
1.3
—
—
—
0
0
11
45
2.45
1.93
1.0
1.5
—
—
—
0
0
85
634
1.35
1.92
1.3
1.2
6.96
9.88
u/ml
0.25
12
104
93
704
1.33
1.90
3.3
3.2
30.51
75.43
mg/l
1.49
72
574
29
173
1.68
1.89
1.7
1.8
—
—
—
0
0
90
679
1.33
1.89
1.3
1.2
100.88
30.97
u/ml
—
6
37
27
158
1.71
1.88
1.1
1.2
—
—
—
0
0
473
4224
1.14
1.88
1.3
1.3
29.64
30.31
iu/ml
0.06
156
1391
70
510
1.38
1.84
1.3
1.2
40.86
43.06
u/ml
—
8
55
7
23
3.05
1.80
1.7
1.1
—
—
—
0
0
83
624
1.34
1.79
1.3
1.2
5.15
3.38
u/ml
—
8
61
246
2098
1.19
1.79
2.5
2.3
12.83
13.12
nmol/l
0.24
220
1910
494
4447
1.13
1.74
2.9
3.0
2.44
2.45
mmol/l
0.14
426
3887
37
241
1.54
1.73
1.4
1.9
—
—
—
0
0
2398
24600
0.91
1.71
4.3
4.2
1.43
1.43
mmol/l
0.18
2227
22835
40
267
1.50
1.68
1.9
1.7
—
—
—
0
0
24
141
1.71
1.68
1.0
1.1
4.97
10.40
iu/ml
—
6
42
263
2272
1.17
1.66
1.9
1.8
—
—
—
0
0
26
157
1.66
1.65
1.1
1.2
—
—
—
0
0
33
212
1.56
1.65
1.4
1.6
1.00
1.33
promille
0.73
27
164
10
41
2.44
1.64
1.0
1.1
1.21
1.63
mmol/l
—
5
28
71
532
1.34
1.60
1.7
1.4
24.61
28.73
e6/l
0.09
56
409
71
532
1.34
1.60
1.7
1.5
574.58
1531.00
e6/l
0.82
57
435
6
20
3.00
1.58
1.0
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
18
99
1.82
1.57
5.2
2.2
160.67
141.46
%
0.34
18
94
74
565
1.32
1.49
1.6
1.7
8561.44
14003.41
e6/l
1.28
55
410
135
1110
1.23
1.49
4.3
2.5
0.63
0.65
%
0.25
135
1102
19
109
1.75
1.46
1.5
2.9
105.67
134.87
umol/l
0.28
12
64
22
132
1.67
1.45
1.2
1.4
147.95
139.26
nmol/l
0.20
22
132
2570
25156
1.10
1.45
18.1
13.9
24.03
24.00
mg/l
0.02
2126
19941
233
2023
1.16
1.42
3.2
2.9
198.87
219.41
ng/l
0.36
207
1817
23
141
1.64
1.41
1.6
1.9
—
—
—
0
0
38
262
1.46
1.41
1.3
1.4
280.62
279.72
mosm/kgh2o
0.07
26
193
50
363
1.38
1.40
1.1
1.1
—
—
—
0
0
53
390
1.36
1.38
1.1
1.1
4.92
1543.59
iu/ml
0.54
13
86
2424
24776
0.92
1.37
4.3
4.2
4.64
4.68
mmol/l
1.13
2257
23112
57
425
1.35
1.37
1.7
1.8
—
—
—
0
0
9
41
2.20
1.37
2.1
1.7
—
—
—
0
0
14
75
1.87
1.34
1.6
1.4
10.65
8.56
ug/l
0.75
14
75
55
410
1.35
1.33
1.9
1.2
25.54
38.07
u/l
0.73
48
351
54
402
1.35
1.32
5.1
5.4
364.88
360.87
umol/l
0.08
48
343
50
368
1.36
1.31
2.4
3.6
0.94
1.40
%
0.90
44
330
1787
17276
1.07
1.30
3.4
3.1
48.37
48.87
u/l
0.07
1683
16226
5
18
2.78
1.28
1.2
1.0
—
—
—
0
0
83
659
1.27
1.28
2.2
1.9
204.69
207.99
pmol/l
0.09
83
625
67
518
1.30
1.27
2.6
2.9
36.44
36.27
umol/l
0.02
59
469
29
194
1.50
1.26
1.2
1.2
6.18
0.71
u/ml
1.04
17
101
61
466
1.31
1.26
1.6
1.7
—
—
—
0
0
28
186
1.51
1.26
2.0
2.3
849.57
634.26
ml
1.22
21
121
41
294
1.40
1.26
2.6
2.2
16.29
22.39
mg/l
0.74
14
82
34
236
1.45
1.24
1.5
1.8
51.20
20.85
ug/l
0.49
34
230
30
203
1.48
1.24
1.2
1.1
47.67
40.83
mg/l
0.29
23
164
45
329
1.37
1.24
1.2
1.1
14.63
4.11
u/ml
0.82
19
122
9
45
2.00
1.23
1.4
1.1
85.89
95.58
%
—
9
45
26
171
1.52
1.23
1.2
1.1
—
4.50
—
0
8
41
296
1.39
1.22
1.2
1.3
—
—
—
0
0
11
56
1.97
1.22
1.2
1.2
45.98
38.13
ug/l
—
5
26
437
3997
1.11
1.20
1.3
1.3
12.73
11.30
u/ml
0.15
169
1631
317
2848
1.13
1.20
2.9
2.7
7.14
8.24
umol/l
0.75
278
2471
24
156
1.54
1.20
1.9
2.0
—
—
—
0
0
11
57
1.93
1.17
1.5
1.2
211.17
270.39
pmol/l
—
6
41
1179
11273
1.07
1.13
2.8
2.5
—
—
—
0
0
32
225
1.43
1.12
1.6
1.4
18.28
30.63
%
1.35
18
131
19
119
1.60
1.11
1.4
1.5
1.50
4.16
%
—
6
25
23
151
1.53
1.11
1.6
1.6
7.13
6.07
u/l
0.14
18
125
82
665
1.24
1.09
1.7
2.1
10.84
10.94
mg/l
0.04
74
615
21
136
1.55
1.08
1.3
1.4
—
—
—
0
0
21
137
1.54
1.05
1.3
1.4
—
—
—
0
0
20
129
1.55
1.05
1.4
1.4
23.57
26.41
umol/l
0.16
20
123
2478
25221
0.93
1.05
4.7
4.6
2.76
2.79
mmol/l
0.82
2291
23401
385
3528
1.10
1.04
1.5
1.4
—
—
—
0
0
2400
23534
1.07
1.04
15.9
12.7
83.28
82.07
ml/min/173m2
1.91
2012
19623
19
122
1.56
1.02
1.8
1.3
86.88
67.23
%
—
8
13
58
456
1.28
1.02
1.4
1.2
317.07
277.54
u/ml
0.36
40
286
86
708
1.22
1.02
1.6
1.4
273.02
288.99
ug/g
0.32
53
402
39
291
1.34
0.99
1.6
1.6
62.68
59.77
%
0.15
19
180
27
189
1.43
0.99
1.1
1.1
—
—
—
0
0
13
76
1.71
0.98
1.4
2.4
54060.00
24420.94
e6/l
—
8
48
26
181
1.44
0.98
1.2
1.1
—
33.25
—
0
8
557
5210
1.08
0.97
4.5
4.0
1.02
1.02
kg/l
0.38
90
735
312
2843
1.11
0.96
4.1
4.2
32.41
31.77
%
0.42
222
1976
23
157
1.47
0.96
1.6
1.5
—
—
—
0
0
67
542
1.24
0.95
1.5
1.6
—
—
—
0
0
282
2559
1.11
0.94
2.0
1.9
—
—
—
0
0
116
992
1.18
0.93
1.6
1.7
5.86
4.28
mg/l
0.28
89
734
441
4095
1.09
0.92
3.6
2.7
1.11
1.29
e6/l
0.39
261
2314
52
410
1.27
0.91
1.1
1.1
—
—
—
0
0
20
134
1.50
0.91
1.6
1.5
—
—
—
0
0
6
28
2.14
0.91
1.2
1.2
—
—
—
0
0
61
491
1.25
0.91
1.3
1.2
—
—
—
0
0
6
29
2.07
0.89
3.7
2.4
0.17
0.97
u/field
—
6
29
6
29
2.07
0.89
1.8
1.4
—
—
—
0
0
44
342
1.29
0.87
1.7
1.6
—
—
—
0
0
219
1970
1.12
0.87
2.8
2.5
68.16
68.55
ml/min/173m2
0.04
83
774
6
30
2.00
0.87
1.2
1.4
89.67
114.73
ng/l
—
6
30
14
88
1.59
0.84
1.1
1.0
—
—
—
0
0
14
88
1.59
0.84
1.6
1.6
—
—
—
0
0
2770
28018
0.93
0.83
25.6
20.2
40.30
40.36
%
0.21
2601
26303
44
347
1.27
0.80
1.2
1.0
2.06
2.74
u/ml
0.30
17
152
18
122
1.48
0.80
1.1
1.1
—
41.92
—
0
12
2776
28067
0.93
0.79
25.5
20.3
135.12
136.22
g/l
3.33
2729
27644
2364
24019
0.94
0.78
4.5
4.3
5.98
5.94
mmol/l
0.73
2179
21998
167
1493
1.12
0.76
3.4
3.4
4.41
4.48
pmol/l
0.40
153
1323
45
560
0.80
0.76
4.1
3.5
15.31
26.12
mg/l
2.79
22
356
62
513
1.21
0.75
6.1
2.1
1.06
0.86
nmol/l
0.63
51
437
9
53
1.70
0.75
1.0
1.2
—
—
—
0
0
32
244
1.31
0.75
1.3
1.2
—
—
—
0
0
40
504
0.79
0.75
4.9
3.1
8.64
7.53
mmol/l
1.34
40
490
2777
28065
0.93
0.75
25.4
20.2
6.89
6.76
e9/l
2.14
2703
27301
17
116
1.47
0.74
2.3
2.7
—
—
—
0
0
7
38
1.84
0.73
1.1
1.2
—
—
—
0
0
2777
28061
0.93
0.73
25.3
20.1
4.49
4.52
e12/l
2.42
2694
27298
9
55
1.64
0.73
1.0
1.1
—
—
—
0
0
136
1205
1.13
0.73
1.1
1.1
—
—
—
0
0
10
60
1.67
0.72
1.0
1.3
18.18
16.88
umol/l
—
10
55
19
134
1.42
0.71
1.7
1.5
—
—
—
0
0
2190
21525
1.05
0.70
20.5
16.4
14.82
14.99
%
0.32
2143
21113
9
59
1.53
0.68
1.1
1.2
—
—
—
0
0
2776
28034
0.94
0.67
25.3
20.1
253.91
250.62
e9/l
1.86
2704
27343
233
2534
0.91
0.67
1.7
1.7
—
—
—
0
0
17
119
1.43
0.66
1.0
1.1
106.94
97.57
%
0.65
17
97
28
215
1.30
0.65
1.3
1.5
—
—
—
0
0
60
505
1.19
0.64
1.7
1.4
—
—
—
0
0
32
251
1.28
0.64
4.0
2.6
—
—
—
0
0
5
29
1.73
0.64
7.4
8.7
5.16
6.59
mmol/l
—
5
29
16
112
1.43
0.63
1.3
1.6
—
—
—
0
0
16
112
1.43
0.63
1.3
1.6
—
—
—
0
0
695
6657
1.06
0.63
2.8
2.5
3444.85
4776.15
umol/l
0.42
600
5857
11
71
1.55
0.62
1.1
1.2
—
—
—
0
0
5
30
1.67
0.61
1.2
1.0
—
—
—
0
0
14
96
1.46
0.61
2.1
2.1
149.71
146.67
nmol/l
0.05
14
81
161
1460
1.11
0.61
4.9
3.1
125.81
129.67
g/l
1.42
161
1423
356
3343
1.07
0.61
1.8
1.9
1.51
1.46
%
0.47
310
2977
406
3831
1.07
0.61
3.8
2.9
2.73
2.31
e6/l
0.38
226
2060
55
463
1.19
0.60
1.4
1.7
—
—
—
0
0
18
131
1.38
0.59
1.6
1.4
1.64
1.29
nmol/l
0.67
13
102
135
1216
1.11
0.59
1.4
1.4
—
—
—
0
0
83
727
1.15
0.56
1.2
1.1
—
—
—
0
0
71
817
0.87
0.56
1.4
1.4
—
—
—
0
0
37
302
1.23
0.55
1.3
1.3
5.62
36.30
u/ml
—
5
15
21
273
0.77
0.54
1.8
1.5
—
—
—
0
0
6
38
1.58
0.54
1.7
1.4
155.83
130.58
ug/l
—
6
33
36
294
1.23
0.54
1.1
1.0
0.10
0.23
u/ml
0.65
13
74
2297
22670
1.04
0.53
4.8
4.6
1.87
2.08
mu/l
0.92
2120
20882
19
143
1.33
0.52
1.4
1.4
—
279.23
—
0
13
82
723
1.14
0.52
1.2
1.2
—
—
—
0
0
6
97
0.62
0.52
1.7
1.2
4.23
4.31
umol/l
—
6
90
652
6272
1.05
0.51
1.6
1.6
1.42
1.42
mmol/l
0.03
541
5348
44
370
1.19
0.50
1.3
1.3
—
—
—
0
0
93
829
1.13
0.50
3.0
2.2
10.13
10.36
g/l
0.17
83
744
2583
25573
1.05
0.50
19.8
15.8
139.44
139.62
mmol/l
2.92
2506
24919
32
390
0.82
0.50
1.1
1.0
2.38
2.35
u/ml
0.01
13
188
22
171
1.29
0.49
1.1
1.1
—
—
—
0
0
22
171
1.29
0.49
1.1
1.1
—
—
—
0
0
24
191
1.26
0.46
1.6
2.1
13.09
7.39
umol/l
0.88
16
129
7
49
1.43
0.46
1.7
2.2
15.93
15.77
umol/l
—
7
49
22
174
1.27
0.44
1.1
1.1
—
—
—
0
0
22
174
1.27
0.44
1.1
1.1
—
—
—
0
0
22
174
1.27
0.44
1.1
1.1
—
—
—
0
0
54
469
1.15
0.44
2.6
3.5
13996.28
884.00
u/ml
0.58
48
441
14
104
1.35
0.43
1.2
1.1
2144.29
1506.19
miu/ml
1.67
14
104
39
331
1.18
0.42
1.1
1.3
0.67
0.61
nmol/l
0.55
39
318
98
888
1.11
0.42
2.9
2.1
3.69
3.70
g/l
0.02
88
805
16
122
1.31
0.42
2.8
1.8
2.30
2.41
u/field
—
10
90
98
889
1.11
0.42
2.9
2.1
7.70
7.39
g/l
0.81
88
806
98
889
1.11
0.42
2.9
2.1
—
—
—
0
0
92
832
1.11
0.41
2.8
2.2
3.02
2.97
g/l
0.19
81
749
0
16
0.00
0.41
0.0
1.3
—
21.03
—
0
6
28
231
1.21
0.41
1.1
1.3
5.67
6.55
mmol/l
0.89
22
216
0
17
0.00
0.40
0.0
4.6
—
—
—
0
0
14
183
0.76
0.40
2.0
1.5
93.79
80.01
umol/l
1.59
14
183
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
21
168
1.25
0.40
1.2
1.2
—
—
—
0
0
21
168
1.25
0.40
1.2
1.2
—
—
—
0
0
46
399
1.16
0.40
1.2
1.1
0.91
1.62
u/ml
0.69
19
184
5
35
1.43
0.39
1.8
1.7
169.80
23.04
pmol/l
—
5
30
15
115
1.31
0.38
1.0
1.1
—
—
—
0
0
2587
25660
1.04
0.38
20.1
15.9
3.98
3.98
mmol/l
0.10
2502
24966
77
694
1.11
0.38
2.9
2.1
37.00
37.58
g/l
0.30
67
612
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
5
36
1.39
0.38
2.8
2.9
—
—
—
0
0
80
723
1.11
0.38
1.3
1.4
10.60
9.15
u/l
0.40
67
582
43
494
0.87
0.38
1.4
1.7
—
—
—
0
0
9
69
1.31
0.37
1.0
1.0
—
—
—
0
0
21
170
1.24
0.37
1.3
1.3
1.40
1.55
g/l
1.98
21
170
8
115
0.69
0.37
1.3
1.1
—
—
—
0
0
37
428
0.86
0.36
1.5
1.4
—
—
—
0
0
53
469
1.13
0.36
1.3
1.1
0.53
1.96
u/ml
2.39
25
222
69
622
1.11
0.35
3.1
2.2
0.00
0.00
g/l
-0.00
63
574
44
386
1.14
0.34
1.3
1.4
0.25
0.42
nmol/l
2.02
36
302
15
118
1.27
0.33
1.7
2.0
—
—
—
0
0
22
263
0.84
0.32
2.2
2.2
—
—
—
0
0
92
848
1.09
0.31
3.4
3.4
98.51
4934.33
u/ml
0.86
79
724
17
138
1.23
0.30
1.2
1.2
—
—
—
0
0
69
629
1.10
0.30
3.1
2.2
0.01
0.00
g/l
0.49
63
575
28
240
1.17
0.30
1.4
1.4
159.18
199.22
pmol/l
0.46
28
240
599
5834
1.03
0.29
2.7
2.3
—
—
—
0
0
65
592
1.10
0.29
1.2
1.2
—
—
—
0
0
65
592
1.10
0.29
2.0
1.9
5.16
4.68
iu/l
0.10
20
227
141
1327
1.07
0.29
1.3
1.3
22.51
27.26
iu/l
1.15
121
1133
14
112
1.25
0.28
2.1
2.1
15.86
92.54
ug/l
0.55
14
98
46
413
1.12
0.27
2.1
1.9
4.16
5.16
mmol/24h
1.88
39
362
20
168
1.19
0.27
1.3
1.8
—
—
—
0
0
81
750
1.08
0.26
2.9
2.3
0.98
1.07
g/l
0.06
71
656
25
215
1.16
0.26
1.3
1.8
—
—
—
0
0
25
215
1.16
0.26
1.3
1.8
—
—
—
0
0
25
215
1.16
0.26
1.3
1.8
—
—
—
0
0
154
1624
0.95
0.26
1.2
1.2
147.74
153.66
iu/ml
0.06
57
612
30
342
0.88
0.26
1.4
1.4
—
—
—
0
0
32
281
1.14
0.26
1.2
1.4
325.88
338.72
pmol/l
0.07
25
245
9
74
1.22
0.25
2.0
2.9
—
—
—
0
0
9
74
1.22
0.25
2.0
2.9
—
—
—
0
0
24
207
1.16
0.25
1.3
1.3
—
—
—
0
0
84
782
1.08
0.25
1.7
1.8
—
—
—
0
0
1899
18815
1.02
0.24
4.1
3.9
14.88
14.71
pmol/l
2.16
1762
17224
655
6691
0.97
0.24
3.7
3.8
22.29
21.49
%
0.50
273
2935
72
667
1.08
0.24
3.0
2.2
0.02
0.02
g/l
0.05
66
610
70
755
0.93
0.24
2.4
2.2
4838.67
5103.81
u/l
0.02
22
273
5
38
1.32
0.23
3.4
2.0
—
—
—
0
0
5
39
1.28
0.23
1.2
1.3
—
—
—
0
0
2661
26741
0.97
0.22
11.5
9.9
26.40
27.31
u/l
1.84
2563
25874
10
79
1.27
0.22
1.6
3.6
—
—
—
0
0
28
315
0.89
0.21
3.0
2.3
105.57
105.74
mmol/l
0.07
28
309
28
315
0.89
0.21
3.0
2.3
4.15
4.06
mmol/l
0.71
28
309
0
11
0.00
0.21
0.0
1.0
—
93.80
—
0
5
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
19
220
0.86
0.21
1.4
1.4
—
—
—
0
0
21
182
1.15
0.21
1.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
12
98
1.23
0.21
1.6
2.3
—
—
—
0
0
12
98
1.23
0.21
1.6
2.3
—
—
—
0
0
23
201
1.15
0.21
2.5
2.2
4.00
2.35
u/field
—
10
77
70
750
0.93
0.21
1.5
1.5
—
—
—
0
0
32
287
1.12
0.20
1.8
1.5
—
—
—
0
0
37
407
0.91
0.20
1.4
1.3
—
—
—
0
0
12
99
1.21
0.19
1.9
2.3
—
—
—
0
0
25
281
0.89
0.19
1.9
1.7
—
—
—
0
0
37
406
0.91
0.19
1.4
1.3
—
—
—
0
0
46
499
0.92
0.19
1.7
1.4
—
—
—
0
0
37
405
0.91
0.18
1.4
1.3
—
—
—
0
0
37
405
0.91
0.18
1.4
1.3
—
—
—
0
0
66
703
0.94
0.18
1.5
1.4
—
—
—
0
0
42
387
1.09
0.17
1.1
1.2
3.07
4.77
u/ml
0.76
14
171
32
291
1.10
0.17
1.8
1.5
—
—
—
0
0
305
2973
1.03
0.17
7.6
7.1
—
—
—
0
0
19
215
0.88
0.16
7.2
5.0
819.08
87.90
u/ml
—
5
64
10
120
0.83
0.16
1.4
1.4
8.90
7.91
mmol/l
—
10
115
43
398
1.08
0.16
1.1
1.1
—
—
—
0
0
8
69
1.16
0.16
2.4
1.8
—
—
—
0
0
19
214
0.89
0.15
1.0
1.1
292.68
280.79
mg/l
0.30
19
194
13
111
1.17
0.15
1.1
1.3
112.69
172.72
mmol/24h
2.32
13
111
27
296
0.91
0.14
1.1
1.1
—
—
—
0
0
11
93
1.18
0.14
1.5
1.3
—
—
—
0
0
12
103
1.17
0.13
1.1
1.3
—
—
—
0
0
31
286
1.08
0.13
1.8
1.5
—
—
—
0
0
31
286
1.08
0.13
1.8
1.5
—
—
—
0
0
69
724
0.95
0.13
1.2
1.3
234.70
200.97
miu/ml
0.33
27
332
12
138
0.87
0.13
1.3
1.3
—
—
—
0
0
31
287
1.08
0.12
1.8
1.5
—
—
—
0
0
444
4372
1.02
0.12
1.6
1.5
—
—
—
0
0
18
162
1.11
0.11
1.0
1.0
—
—
—
0
0
89
924
0.96
0.11
1.8
1.9
—
—
—
0
0
12
105
1.14
0.11
1.4
1.4
—
—
—
0
0
12
105
1.14
0.11
1.4
1.4
—
—
—
0
0
31
290
1.07
0.10
1.8
1.5
—
—
—
0
0
5
45
1.11
0.09
1.2
1.4
—
—
—
0
0
6
55
1.09
0.08
1.0
1.1
—
—
—
0
0
79
765
1.03
0.08
1.5
1.3
—
—
—
0
0
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
16
146
1.10
0.08
1.0
1.1
0.93
1.10
u/l
—
9
77
2283
22893
0.99
0.08
6.1
5.4
40.23
39.70
mmol/mol
1.68
2117
21298
11
123
0.89
0.08
1.1
1.3
734.82
344.96
u/l
0.28
11
111
40
419
0.95
0.08
1.1
1.1
0.22
1.26
u/ml
2.17
14
161
8
74
1.08
0.07
1.5
1.1
—
—
—
0
0
7
81
0.86
0.07
1.4
2.1
—
34293.79
—
0
14
17
157
1.08
0.07
2.0
3.0
43.92
41.45
%
0.26
12
86
13
118
1.10
0.07
3.2
3.8
—
—
—
0
0
11
122
0.90
0.07
1.1
1.1
—
—
—
0
0
93
907
1.03
0.07
1.4
1.6
282.79
296.78
mu/l
0.17
84
828
29
275
1.06
0.06
1.4
1.4
4645.57
1675.31
e6/l
0.56
23
192
24
227
1.06
0.06
1.2
1.3
—
—
—
0
0
134
1317
1.02
0.05
2.1
1.8
—
—
—
0
0
37
384
0.96
0.05
1.5
1.4
27.11
25.28
u/l
0.14
31
311
13
120
1.08
0.04
1.3
3.8
—
—
—
0
0
38
392
0.97
0.04
1.2
1.2
1.38
3.95
u/ml
1.89
13
123
13
139
0.93
0.03
2.4
7.6
—
53.80
u/ml
—
0
41
836
8387
1.00
0.03
4.2
4.3
2.23
3.17
ug/l
0.86
754
7549
22
229
0.96
0.02
1.0
1.0
—
—
—
0
0
43
440
0.98
0.02
1.1
1.1
2.89
4.80
u/ml
0.71
19
212
485
4869
1.00
0.02
2.8
2.8
0.72
0.75
ug/l
0.38
303
2995
18
172
1.05
0.02
2.0
1.6
—
—
—
0
0
20
192
1.04
0.02
2.0
1.6
—
—
—
0
0
13
124
1.05
0.00
1.5
2.1
—
—
—
0
0
13
124
1.05
0.00
1.5
2.1
—
—
—
0
0
22
226
0.97
0.00
1.3
1.4
1.89
3.51
ug/l
1.03
17
196
102
1015
1.01
0.00
2.0
1.8
—
—
—
0
0
51
508
1.00
0.00
3.5
3.1
0.94
0.84
nmol/l
0.35
40
393
70
703
1.00
0.00
1.1
1.1
4.16
4.15
u/ml
—
7
94
0
8
0.00
0.00
0.0
1.0
—
1141.63
—
0
8
0
5
0.00
-0.00
0.0
12.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
13.6
—
1660.57
—
0
7
5
56
0.89
-0.00
1.4
1.3
—
—
—
0
0
9
89
1.01
-0.00
1.4
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
10.2
—
—
—
0
0
5
57
0.88
-0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES | 1.847 [1.66, 2.06] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.14 |
During the follow-up period (1.1.1998 — 31.12.2019), 1440 out of 2917 females with AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES | 2.058 [1.82, 2.33] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 2077 out of 3401 males with AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES died.
Mortality risk
Mortality risk for people of age
years, who have AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.149% | 0.359% |
| 5 | 0.929% | 2.127% |
| 10 | 2.57% | 5.136% |
| 15 | 4.969% | 10.246% |
| 20 | 8.474% | 17.367% |
Relationships between endpoints
↥Index endpoint: AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES – Sequelae of infectious and parasitic diseases
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data